GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
0.7120
-0.0080 (-1.11%)
Jan 23, 2026, 4:00 PM EST - Market closed
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $7.57 million as of January 23, 2026. Its market cap has increased by 13.03% in one year.
Market Cap
7.57M
Enterprise Value
5.04M
1-Year Change
13.03%
Ranking
Category
Stock Price
$0.71
Market Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $7.57M, a decrease of -90.90%. That is a compound annual growth rate of -26.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 7.70M | -7.23% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptorum Group | 8.14M |
| Quoin Pharmaceuticals | 8.10M |
| Kiora Pharmaceuticals | 8.07M |
| Calidi Biotherapeutics | 7.90M |
| Abpro Holdings | 7.88M |
| Addex Therapeutics | 7.85M |
| Mustang Bio | 7.81M |
| Creative Medical Technology Holdings | 7.72M |